Drug-induced movement disorder: A disproportionality analysis using the FDA adverse event reporting system (FAERS) from 2004 to 2024

Jingjing Zou; Chenju Zhan; Yan Feng; Qixi Liu; Guohao Peng; Zhongjie Cai; Lingling Luo; Jun Zou

doi:10.1371/journal.pone.0335449

Loading metrics

Open Access

Peer-reviewed

Research Article

Drug-induced movement disorder: A disproportionality analysis using the FDA adverse event reporting system (FAERS) from 2004 to 2024

Jingjing Zou ,

Contributed equally to this work with: Jingjing Zou, Chenju Zhan

Roles Methodology, Writing – original draft, Writing – review & editing

Affiliation Department of Nursing, Mindong Hospital Affiliated to Fujian Medical University, Ningde, China
⨯
Chenju Zhan ,

Contributed equally to this work with: Jingjing Zou, Chenju Zhan

Roles Methodology, Writing – original draft, Writing – review & editing

Affiliation Department of Nursing, Mindong Hospital Affiliated to Fujian Medical University, Ningde, China
⨯
Yan Feng,

Roles Resources

Affiliation Department of Nursing, Mindong Hospital Affiliated to Fujian Medical University, Ningde, China
⨯
Qixi Liu,

Roles Resources

Affiliation Department of Nursing, Mindong Hospital Affiliated to Fujian Medical University, Ningde, China
⨯
Guohao Peng,

Roles Data curation, Validation

Affiliation Department of Endocrinology, Mindong Hospital Affiliated to Fujian Medical University, Ningde, China
⨯
Zhongjie Cai,

Roles Software

Affiliation Department of Pharmacy, Mindong Hospital Affiliated to Fujian Medical University, Ningde, China
⨯
Lingling Luo,

Roles Software

Affiliation Department of Pharmacy, Mindong Hospital Affiliated to Fujian Medical University, Ningde, China
⨯
Jun Zou

Roles Conceptualization, Data curation, Methodology, Validation, Writing – review & editing

* E-mail: zou_jun1024@163.com

Affiliation Department of Pharmacy, Mindong Hospital Affiliated to Fujian Medical University, Ningde, China

https://orcid.org/0009-0001-5943-2604

⨯

Drug-induced movement disorder: A disproportionality analysis using the FDA adverse event reporting system (FAERS) from 2004 to 2024

Jingjing Zou,
Chenju Zhan,
Yan Feng,
Qixi Liu,
Guohao Peng,
Zhongjie Cai,
Lingling Luo,
Jun Zou

Published: October 31, 2025
https://doi.org/10.1371/journal.pone.0335449

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Dopamine
Is the Subject Area "Dopamine" applicable to this article?

Thanks for your feedback.
Movement disorders
Is the Subject Area "Movement disorders" applicable to this article?

Thanks for your feedback.
Adverse reactions
Is the Subject Area "Adverse reactions" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Neurotransmitters
Is the Subject Area "Neurotransmitters" applicable to this article?

Thanks for your feedback.
Drug safety
Is the Subject Area "Drug safety" applicable to this article?

Thanks for your feedback.
Levodopa
Is the Subject Area "Levodopa" applicable to this article?

Thanks for your feedback.